About NeuraLeap Labs
Our Mission
At NeuraLeap Labs, our mission is to revolutionize the treatment of brain disorders, including Mild Cognitive, Impairment (MCI), Traumatic Brain Injury (TBI), and adult Learning Disabilities (LD). We strive to deliver the first FDA-approved therapy for brain disorders that utilizes advanced neuroimaging, individualized treatment using AI, and non-invasive brain stimulation.
Welcome!
We are transitioning cutting-edge neuroscience research in personalized brain treatment to address the challenges that come from brain disorders.